HL Select Global Growth Shares

HL Select Global Growth Fund – Q4 2025 Review

In this update, Head of Equity Funds Steve Clayton provides a market overview, reviews fund performance, highlights key portfolio activity, and shares the outlook for the HL Select Global Growth Shares fund.
HL Select Global Growth Fund - Q3 2025 Review (image)

The value of this fund can still fall so you could get back less than you invested, especially over the short term. The information shown is not personal advice and the information about individual companies represents our view as managers of the fund. It is not a personal recommendation to invest in a particular company. If you are at all unsure of the suitability of an investment for your circumstances please contact us for personal advice. The HL Select Funds are managed by our sister company HL Fund Managers Ltd.

Market Review

Global equity markets made further progress in Q4, with the MSCI World Index delivering a total return of 3.2%. Investor sentiment was buoyed by signs that economies were coping with the new tariff regimes, with modest growth and easing inflation. This allowed major Western central banks to ease interest rates further in December.

Health Care stocks led markets higher, with the global sector adding almost 11% in value. Real Estate was the only losing major industry, declining by 2.2%. Commodity price strength, from precious metals to copper helped mining stocks to advance, whilst financial services benefited from lower interest rates. Technology was something of a laggard, advancing by just 1.4% as a degree of scepticism over AI emerged.

Fund Review

The HL Select Global Growth shares fund declined in value by 0.3% over the quarter. The headwinds facing growth-oriented investors that we have discussed previously remained in place. These were compounded by some weak outcomes from individual stocks.

Politics continued to be dominated by the emergence of right-leaning populist parties on this side of the Atlantic and of course the words and actions of President Trump on the other side. 2026 has of course seen the latter moving centre stage, but so far with relatively little impact upon equity markets.

Currencies played little role in explaining market movements in Q4, whilst bond yields were generally unhelpful, with long-dated government bond yields pushing higher in the US and Europe. UK gilts stood out as outperformers, with yields falling slightly, which will have been welcomed by the Bank of England as a sign that markets were comfortable about the UK’s medium to longer term fiscal outlook.

01/01/2021 to 31/12/2021

01/01/2022 to 31/12/2022

01/01/2023 to 31/12/2023

01/01/2024 to 31/12/2024

01/01/2025 to 31/12/2025

HL Select Global Growth Shares A GBP Acc

12.44

-18.00

21.18

15.29

0.44

FTSE World TR GBP

22.07

-7.15

17.18

20.07

14.97

IA Global

17.57

-11.34

12.66

12.80

10.81

MSCI World NR USD

22.94

-7.83

16.81

20.79

12.75

Past performance isn't a guide to future.
Source: *Morningstar Direct to 31/12/25

The Winners

Alphabet, the parent company of Google was far and away the largest positive contributor during Q4 adding 1.1% to the value of your fund. Not long ago Alphabet was seen as at risk from AI, which it was felt could threaten the value of Search. However, as it became clear that Google had deftly integrated the group’s own AI capabilities into the core search engine sentiment turned sharply, enabling the stock to rally strongly.

With signs that tariffs were failing to seriously disrupt much of global trading activity the luxury sector enjoyed something of a relief rally and LVMH as the largest player benefited accordingly. We think the picture remains somewhat clouded, for many brands moved stock around the globe in advance of tariffs taking effect. As these positions unwind we should get a clearer view, but it appears that customer demand for luxury goods remains strong.

As mentioned previously, Health Care was the strongest sector during Q4 so it is unsurprising to see sector stalwart Danaher joining in. Their Q3 earnings report delivered growth ahead of market forecasts, with a solid outlook for the year ahead.

API Group has been one of the fund’s stronger performers in 2025 and this continued through Q4. The group provides safety services around the world, with sales often driven by regulatory imperatives. This gives it a solid base of dependable turnover. Recurring revenues like these are a quality that we value highly because they can reduce volatility of earnings and make higher growth rates achievable.

Amphenol delivered another solid performance, cementing its position as our most successful investment in the fund’s history. The company delivered well received Q3 results, driven by strength in their communications division. Amphenol’s product range gives them exposure to the massive growth in datacentre building in the US and elsewhere. Their products both ease the delivery of power onto site and the pace of data transmission around the centres too. This should provide the group with strong underlying demand for some time.

Past performance isn’t a guide to the future.
Source: Bloomberg (30/09/25 – 31/12/25)

The chart highlights the five strongest contributors to performance this quarter. Hover over each bar for more detail.

The Losers

Fiserv Inc. delivered a sharp profit warning and effectively admitted that it had previously overstated its performance. Fiserv had previously seen its CEO depart to take up a position in the Trump administration. Perhaps we should have viewed that and some earlier weakness in guidance as a warning flag. Either way the company has sharply lowered its expected growth, including within its key Clover payments business which we regarded as core to the future value of the group. We had at least reduced the position earlier in the year, which limited the impact and we have now fully exited from the position.

Microsoft is a large position so small changes in its price tend to impact on the value of the fund. The stock suffered a little from a more sceptical approach by the market toward AI players but we are not aware of any tangible reasons for the modest drop in the share price during Q4.

Phreesia continues to act as a drag on performance. We have had great hopes for the long-term value of their technology, which helps improve the operational and financial performance of health care practices, predominantly in the USA. However, transforming this potential into profit has taken far longer than we originally anticipated when we invested back in 2020 and Phreesia has been a meaningful drag on fund performance over the years, despite a promising start.

Motorola Solutions struggled between September and mid-December but has been mounting something of a recovery since. We are at a loss to understand the reasons for the drop in the share price, which fell from just over $480 in September to a low of $363 in mid-December. We see little prospect that their activities, which span the production of communication handsets and network equipment for Police, Fire, Ambulance and other vital services, being disrupted by AI. Nor do we see any shift in the competitive balance versus other existing competitors. The simple truth may be that the stock had simply become too expensive for some holders, but we would argue that there are few companies out there with Motorola Solutions to keep compounding earnings far out into the future.

Australia’s Car Group has been struggling since August. The business is essentially a digital vehicle marketplace, roughly analogous to Auto Trader of the UK. That’s been weak too, since August and that in turn seems to tie in closely with Rightmove’s profit warning issued back then. That warning revealed a need to invest more deeply into the Rightmove’s technology to keep it up to date. We suspect that the market is tarring other online marketplaces with the same brush, without looking at the opportunities specific to Car Group’s international market positions.

Past performance isn’t a guide to the future.
Source: Bloomberg (30/09/25 – 31/12/25)

The chart highlights the five weakest contributors to performance this quarter. Hover over each bar for more detail.

Important

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information. Unless otherwise stated performance figures are from Bloomberg and estimates, including prospective yields, are a consensus of analyst forecasts from Bloomberg. They are not a reliable indicator of future performance. Yields are variable and not guaranteed.

Weekly newsletter
Sign up for editors choice. The week's top investment stories, free in your inbox every Saturday.
Written by
Steve-Clayton-2023
Steve Clayton
Head of Equity Funds

Steve is the Head of our HL Select fund range, using his wealth of experience to craft the overall strategy for the funds. He also provides insightful analysis to clients from a fund manager's perspective, playing a pivotal role in letting clients peek behind the curtain.

Our content review process
The aim of Hargreaves Lansdown's financial content review process is to ensure accuracy, clarity, and comprehensiveness of all published materials
Article history
Published: 26th January 2026